The European Union has decided on common purchasing of a vaccine and antiviral to fight the outbreak of monkeypox, a virus endemic in Africa and usually rare in other places, Sweden’s vaccine coordinator said on Friday. “After several meetings it has been decided that we will buy both vaccine and an antiviral treatment,” Swedish daily Dagens Nyheter quoted coordinator Richard Bergstrom as saying. The paper said the EU would buy Bavarian Nordic’s Imvanex and Tecovirimat from Siga Technologies in the United States.
Read more on CDE News
